Dallas-Based Vaxxinity Prepares for $100M IPO; Aims to Turn Immune Systems Into ‘Antibody Factories’

Vaxxinity’s COVID-19 vaccine candidate is “super safe and mild and doesn’t bring recipients down for a couple of days with flu-like symptoms,” says the company’s co-founder and CEO, Mei Mei Hu. Unlike …
( read original story …)

---